Orbital Therapeutics
Orbital Therapeutics develops RNA-based medicines to treat human disease.
$270M Series A ·
Led by ARCH Venture Partners · Source: fundraisingfox.com
Latest round on record: Series A, August 2025, amount undisclosed.
All 2 rounds ↓Acquired by BBristol-Myers Squibb on for $1.5B · AOL.
Signals
About Orbital Therapeutics
The company uses a platform that combines RNA technology, delivery techniques, data analytics, and automation. It aims to produce an extended portfolio of medications.
Orbital Therapeutics | 383 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | undisclosed | — | fundraisingfox.com | |
| Series A | $270M | fundraisingfox.com |
Timeline
Founders and team
CS
Carol Suh FounderDW
Drew Weissman FounderGY
GC
Giuseppe Ciaramella FounderHC
Howard Chang FounderJM
John Maraganore FounderKB
Kristina Burow FounderRM
Ravi Majeti FounderAR
Adam Raff Senior Vice President, Clinical Development
Investors
AAbu Dhabi Growth Fund
AAgent Capital
AAndreessen Horowitz
AARCH Venture Partnerslead investor
CCasdin Capital
EEXOR N.V.
HHeritage Medical SystemsIiGlobe Partners
IInvus
MMoore Strategic Ventures
NNewpath Management
RRedmile Group
RRellim Capital Management
Companies like Orbital Therapeutics
MMirador Therapeutics$250M Series B+ · Jan 2026
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
AAddition Therapeutics$100M Series A · Dec 2025
RReCode TherapeuticsSeries B+ · Oct 2023CCity TherapeuticsSeries B+ · Aug 2026
AAsher Bio$55M Series B+ · Apr 2024
Other companies backed by ARCH Venture Partners
Bbit.bio$25M Series B+ · Nov 2026
SSoufflé Therapeutics$135M Series B+ · Oct 2026
OOratomic$475M Series B+ · Oct 2026
LLifeMine Therapeutics$75M Series B+ · Aug 2026
SSynchron$275M Series B+ · Jun 2026
LLightcast$27M Series B+ · Apr 2026
ARCH Venture Partners portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/orbital-therapeutics (get a free API key).